contact us
Portola Pharmaceuticals (NASDAQ: PTLA) CEO Bill Lis is retiring from the South San Francisco, CA, drug developer. Lis will also retire from Portola’s board of directors.
Do Not Allow Advertisers to Use My Personal information
